Scientific Research News

News about theoretical and practical scientific research spanning a wide variety of disciplines, including engineering, computer science, biology, physics and chemistry. Includes information about research facilities, funding, resources and public policy.

New Pivotal Data Demonstrates Clinical Feasibility of GeneFluidics’ Direct-from-Specimen AST in Clinical Settings

New Pivotal Data Demonstrates Clinical Feasibility of GeneFluidics’ Direct-from-Specimen AST in Clinical Settings

GeneFluidics, Inc. is pleased to announce a joint publication with the Medical College of Wisconsin (MCW) that introduces rapid antimicrobial susceptibility testing (AST), which would represent a paradigm shift in the clinical management of microbial infections. The data from the MCW study have... - November 04, 2022 - GeneFluidics Inc.

Introducing Wholeview Direct: Delivering Addiction Treatment Directly Into the Homes of New Yorkers

Introducing Wholeview Direct: Delivering Addiction Treatment Directly Into the Homes of New Yorkers

Wholeview Direct, a new, fully virtual, outpatient addiction treatment program has begun to provide treatment throughout the State of New York. - November 01, 2022 - Wholeview Wellness

DistillerSR Launches New CuratorCR Capabilities to More Dynamically Manage and Reuse Evidence-Based Research

CuratorCR Knowledge Center Provides Alternative to Elsevier’s QUOSA Virtual Library as Its Sunset Date Looms. - October 31, 2022 - DistillerSR

UTECH® Products Expands Operations to Abu Dhabi, Totaling Eight International Offices

UTECH® Products Expands Operations to Abu Dhabi, Totaling Eight International Offices

UTECH® Products Inc., a medical and laboratory equipment and supplies company is pleased to announce expanding operations to Abu Dhabi, United Arab Emirates, making it its 8th office worldwide. UTECH is bringing its expansive offerings to the Middle East market as a global leader in medical... - October 25, 2022 - EndoSoft

ASTER Labs, Inc. Awarded SpaceWERX Orbital Prime Contract

ASTER Labs, Inc. has been awarded a STTR Phase I under the SpaceWERX Orbital Prime Program. - October 23, 2022 - ASTER Labs Inc.

Creative Diagnostics Introduces Fluorometric Neuraminidase Assay Service for High-Throughput Discovery

As an expert in the antiviral field providing solutions to assist virology and microbiology research, Creative Diagnostics recently introduced Fluorometric Neuraminidase Assay services to the global research community, suitable for functional detection of NI-resistant viruses in mixed virus... - October 23, 2022 - Creative Diagnostics

Biolexis Therapeutics Announces Launch of FIELDS, an AI/ML Drug Discovery Platform

Biolexis is the first company to combine a curated historical wet-lab database, including half-a-million targets of binding data points, with an automated AI/ML-augmented discovery platform. - October 14, 2022 - Biolexis Therapeutics Inc.

Huntington Study Group Enrolls First Participant for Its Observational Study to Test the Reliability of the Virtual Use of the Unified Huntington’s Disease Rating Scale

Huntington Study Group Enrolls First Participant for Its Observational Study to Test the Reliability of the Virtual Use of the Unified Huntington’s Disease Rating Scale

The Huntington Study Group (HSG), a world leader in conducting clinical trials for Huntington’s Disease (HD) for over 30 years, together with its Clinical Research Organization (“CRO”), the HSG Clinical Research, Inc., today announces the enrollment of the first participant of its... - October 12, 2022 - Huntington Study Group

Mirror Biologics, Inc. Announces Additional $20 Million Investment to Close Out $30 Million Series A Investment Round

Mirror Biologics, Inc. Announces Additional $20 Million Investment to Close Out $30 Million Series A Investment Round

Mirror Biologics, Inc., a clinical stage biopharmaceutical company today announced the completion of the final $20 million tranche of its $30 million Series A investment round with Bradbury Asset Management (Hong Kong), Limited. Bradbury provided an initial $10 million tranche for this round in... - October 11, 2022 - Mirror Biologics, Inc.

ALS Therapy Development Institute Announces Superior Rail & Iron Works, Inc. as First Title Sponsor of White Coat Affair Gala

ALS Therapy Development Institute Announces Superior Rail & Iron Works, Inc. as First Title Sponsor of White Coat Affair Gala

Superior Rail & Iron Works, Inc. will be the first Title Sponsor of the White Coat Affair gala, being held on October 15, 2022, at the Boston Sheraton to raise funds for ALS research. - September 28, 2022 - ALS Therapy Development Institute

Creative Diagnostics Announces the Launch of SARS-CoV-2 ADE Assay

Creative Diagnostics announced the launch of SARS-CoV-2 ADE Assay to support laboratory scientists for SARS-CoV-2 vaccine research. - September 28, 2022 - Creative Diagnostics

New Decentralized Clinical Trial (DCT) Patient Satisfaction and Participation Report

800 Current and Future Clinical Trial Participants Link Satisfaction and Willingness to Participate with Decentralized Strategies - September 21, 2022 - Life Science Strategy Group, LLC

Biomed Industries, Inc. to Acquire MedAware Systems, Inc. to Expand Its Artificial Intelligence Research for Drug Discovery in Alzheimer’s Disease

Biomed Industries, Inc. (“BIOMED” or the “Company”), has entered into a share exchange agreement to acquire all of the issued and outstanding shares of MedAware Systems, Inc. MedAware shares was valued at $1.50 per share and BIOMED’s share was valued at $8.00 per share. The transaction was valued at an aggregate of $18 million, to be paid in the form of 2,259,170 common shares of BIOMED. On the date of the Agreement, BIOMED has approximately 76,354,075 common shares. - September 21, 2022 - Biomed Industries, Inc.

SolarCraft Completes Solar Power Installation for Point Blue Conservation Science in West Marin - Point Reyes Wildlife Institution Increases Sustainability of Operation

SolarCraft Completes Solar Power Installation for Point Blue Conservation Science in West Marin - Point Reyes Wildlife Institution Increases Sustainability of Operation

Novato and Sonoma-based SolarCraft recently completed the installation of a solar electric power installation at Point Blue Conservation Science Facility in the seaside town Bolinas, West Marin County. Located in the heart of the Point Reyes National Seashore, Point Blue, originally known as the Point Reyes Bird Observatory, is harnessing the power of the sun to provide significant utility savings to their facilities. - September 13, 2022 - SolarCraft

NAMIWalks 2022 Returns to Angels Stadium

NAMIWalks 2022 Returns to Angels Stadium

The 2022 NAMIWalks Orange County 5K walk will take place at Angels Stadium on November 19, 2022 at 8:00 a.m. Registration will begin at 7:00 a.m. - September 11, 2022 - NAMI Orange County

"Bullying Causes Brain Damage": Science Shows It Can be Reversed, New Book Reveals

Abuse survivor and mother of a bullying victim uncovers latest neuroscience on pervasive societal harm. - September 01, 2022 - Bullied Brain

High-Level Academic and Government Speakers to Present at Military Event in Alexandria, VA

Are you currently an OR Analyst in the field looking to increase your knowledge in leading-edge approaches, methods, and techniques? You do not want to miss the opportunity to participate in this one-of-a-kind Forum highlighting emerging techniques in OR. If you would like to present at the MORS... - August 26, 2022 - MORS

Creative Diagnostics Launches Custom Virus Production Service

Creative Diagnostics has recently introduced the research community with customized virus production services. - August 26, 2022 - Creative Diagnostics

Hadronic Technologies Notes Importance for Environment of 1935 Argument by A. Einstein, B. Podolsky & N. Rosen That "Quantum Mechanics is Not a Complete Theory"

Hadronic Technologies Notes Importance for Environment of 1935 Argument by A. Einstein, B. Podolsky & N. Rosen That "Quantum Mechanics is Not a Complete Theory"

Professor Ruggero Santilli says that new books recently released and the growing importance of a conference in physics and mathematics point to the insufficiency of quantum mechanics for the achievement of new, clean nuclear energies and to the relevance of the EPR completion of quantum into hadronic mechanics to the solution of our increasingly alarming environmental problems. - August 19, 2022 - Hadronic Technologies, Inc.

VMRD Begins Manufacturing Key Reagent for Detection of CWD by RT-QuIC

VMRD Begins Manufacturing Key Reagent for Detection of CWD by RT-QuIC

Veterinary Medical Research & Development (VMRD), Pullman, WA, has partnered with CWD Evolution, Fort Collins, CO, to provide state-of-the-art diagnostic reagents for detection of the abnormal prion associated with Chronic Wasting Disease (CWD). The control of CWD requires identification of... - August 09, 2022 - VMRD, Inc.

Jedsy to Participate at 2022 AACC

Jedsy to Participate at 2022 AACC

Drone delivery made for Laboratories. - July 25, 2022 - Jedsy

Creative Diagnostics Launches Monkeypox Virus Antibodies and Antigens to Support MPXV Research

Creative Diagnostics announced the launch of several Monkeypox Virus Antibodies and Antigens for the detection of Monkeypox viruses. - July 22, 2022 - Creative Diagnostics

PharmStars Announces Spring 2022 Accelerator Graduates: 11 Digital Health Startups Have Successfully Completed PharmStars’ Pharma-Focused Accelerator Program

PharmStars Announces Spring 2022 Accelerator Graduates: 11 Digital Health Startups Have Successfully Completed PharmStars’ Pharma-Focused Accelerator Program

PharmStars, the pharma-focused accelerator for digital health startups, announces the graduation of 11 startups from its Spring 2022 program. The graduates successfully completed the 10-week PharmaU program, which culminated with the Showcase Event held June 8-10 in Boston. The Showcase Event brought together the participating startups and PharmStars’ seven innovation-minded pharma members. - July 12, 2022 - PharmStars

Immundiagnostik and Preventis GmbH Go Beyond the Lab at the AACC’s Annual Scientific Meeting and Clinical Lab Expo

Immundiagnostik and Preventis GmbH Go Beyond the Lab at the AACC’s Annual Scientific Meeting and Clinical Lab Expo

Immundiagnostik and Preventis GmbH will exhibit together at the upcoming AACC Clinical Lab Expo July 26-28 in Chicago, IL in support of improved patient care. - July 11, 2022 - Immundiagnostik, Inc.

Global Cancer Technology Successfully Concludes Glioblastoma Pre-Clinical Animal Studies with Impressive Results

Global Cancer Technology Successfully Concludes Glioblastoma Pre-Clinical Animal Studies with Impressive Results

Global Cancer Technology, a San Diego, CA biotechnology company, has successfully completed animal testing with GCT.GLIO.1, a PI3K selective inhibitor that can cross the blood brain barrier and modulate immune cell function. The company will advance the compound to Phase 1 clinical trials as a next step. - July 08, 2022 - Global Cancer Technology

Scientific Body Type Quiz from Fellow One Research Offers the First-Ever Science-Based Body Type Identification

Scientific Body Type Quiz identifying genetics, diet, exercise, metabolism, lifestyle, fat, and skinny fat as well as vertebrae and muscle development from the global pioneer in Body Type Science (The Four Body Types) successfully clears two years of real-world case study vetting - is ready for widespread public use. - July 02, 2022 - Fellow One Research

Foundation Supporting Indigenous Students to Return a Half-Million Dollars to a Catholic Organization

Foundation Supporting Indigenous Students to Return a Half-Million Dollars to a Catholic Organization

The Verna J. Kirkness Education Foundation Board Chair, Tony Williams, plans to announce the Board’s decision to return the $500,000 endowment to the Sisters of Saint Anne and terminate the 4.5-year-long relationship. In his announcement, Tony Williams will explain his Board’s decision... - June 24, 2022 - Verna J. Kirkness Foundation

TrialX Launches a DEI Toolkit Within iConnect Platform to Tackle Diversity Challenges in Clinical Trial Recruitment

TrialX Launches a DEI Toolkit Within iConnect Platform to Tackle Diversity Challenges in Clinical Trial Recruitment

To overcome barriers to participation of diverse populations in clinical trials, TrialX launches a toolkit for sponsors and sites to create an end to end multilingual experience for patients. - June 21, 2022 - TrialX

Ocean Research Project's Schooner Marie Tharp Stops in Newport Before Ambitious Maiden Voyage to Map Greenland's Uncharted Glacier Fjords

Schooner Marie Tharp stops in Newport area for final preparations before launching into a decadal ocean mapping campaign across the Arctic. Operated by the Ocean Research Project, Marie embarks on her maiden mission to Greenland led by Captain Matt Rutherford and Oceanographer Nicole Trenholm. - June 20, 2022 - Ocean Research Project

Air & Waste Management Association’s Annual Conference Brings Environmental Scientists to San Francisco, June 27-30

Air & Waste Management Association’s Annual Conference Brings Environmental Scientists to San Francisco, June 27-30

The Air & Waste Management Association’s 115th Annual Conference & Exhibition (ACE) will bring together hundreds of environmental professionals from around the world on June 27-30 in San Francisco, CA. This year’s conference on “Science & Sustainable Global... - June 15, 2022 - Air & Waste Management Association

Creative Diagnostics Launches Measles Virus Antigens for the Detection of Antibodies

Creative Diagnostics announced the release of new measles virus antigens suitable for both IgM and IgG detection. - June 11, 2022 - Creative Diagnostics

Eledon Announces Phase 2a Trial Results of Tegoprubart (AT-1501) – a Drug Invented at ALS TDI

Eledon Announces Phase 2a Trial Results of Tegoprubart (AT-1501) – a Drug Invented at ALS TDI

Eledon Pharmaceuticals announced topline results from their Phase 2 trial of tegoprubart (formerly AT1501), a drug invented and developed at the ALS Therapy Development Institute (ALS TDI). The Phase 2a trial in ALS was a 12-week, open label, dose escalating, safety, and biomarker study. The... - May 31, 2022 - ALS Therapy Development Institute

Scientific Reports Publishes Data Demonstrating VR Platform Produces Peak Experiences, Ego Attenuation & Connectedness Comparable to Moderate Dose Psychedelics

Scientific Reports Publishes Data Demonstrating VR Platform Produces Peak Experiences, Ego Attenuation & Connectedness Comparable to Moderate Dose Psychedelics

aNUma, Inc., a digital therapeutics company building virtual reality programs to address the global mental health crisis, today, announced that Scientific Reports has published research demonstrating technology like that behind aNUma’s VR platform can deliver peak experiences, ego attenuation, and connectedness comparable to psychedelics. This study, written by Dr. David Glowacki and colleagues, is the first of its kind to be published in a leading peer-reviewed journal. - May 30, 2022 - aNUma

Creative Diagnostics Launches Antibody-Dependent Enhancement Assay Services

Creative Diagnostics recently introduces comprehensive services for antibody-dependent enhancement (ADE) assay. - May 26, 2022 - Creative Diagnostics

ALS Therapy Development Institute Scientists to Present Posters Sharing Research Advancements at the ALS Drug Development Summit

ALS Therapy Development Institute Scientists to Present Posters Sharing Research Advancements at the ALS Drug Development Summit

The ALS TDI scientists will be showcasing significant advancements in ALS research through multiple poster presentations. These posters will cover pre-clinical research exploring potential new therapeutic drug-like molecules and targets for ALS, as well as translational research analyzing patient data to identify new ALS biomarkers, drug targets, and patient populations. - May 25, 2022 - ALS Therapy Development Institute

Biopharma Industry Standout Robert Proulx Joins Advisory Board of Global Cancer Technology

Biopharma Industry Standout Robert Proulx Joins Advisory Board of Global Cancer Technology

Global Cancer Technology is developing innovative treatments for deadly diseases like cancer, with a current focus on glioblastoma and breast cancer. To date, Mr. Robert Proulx has held numerous Board positions, is a recognized thought leader in biopharma, and currently holds dual roles as the founder and CEO of Imagion Biosystems. - May 21, 2022 - Global Cancer Technology

Annapolis-Based Ocean Research Project is About to Set Sail Again

Annapolis-Based Ocean Research Project is About to Set Sail Again

The team at Ocean Research Project is about to set sail for Greenland to conduct environmental research to combat climate change. They will be at the City Dock in Annapolis making last minute preparations. Come meet the team. - May 12, 2022 - Ocean Research Project

Mentalab Explore - A New Biosensor to Unlock the Secrets of the Brain

Mentalab is a German neurotech startup with one mission: use modern technology to make real-time biomarkers accessible. To do this, Mentalab has produced a powerful, flexible, and mobile ExG system: the Mentalab Explore. Through smart, minimalistic design, Mentalab Explore can record EEG, ECG,... - May 09, 2022 - Mentalab US LLC

Recognized Ocean Research Team to Unveil Multi-Objective Flagship, R/V Marie Tharp, for Ambitious Iceberg-Packed Expedition During Commissioning

Recognized Ocean Research Team to Unveil Multi-Objective Flagship, R/V Marie Tharp, for Ambitious Iceberg-Packed Expedition During Commissioning

Annapolis-based Ocean Research Project is unveiling its Flagship R/V Marie Tharp as they prepare to embark for an ambitious Iceberg-Packed Expedition. - May 06, 2022 - Ocean Research Project

The ALS TDI Discovery Biology Suite Dedicated in Honor of Liz Bodine to Speed Drug Development in ALS

The ALS TDI Discovery Biology Suite Dedicated in Honor of Liz Bodine to Speed Drug Development in ALS

The ALS Therapy Development Institute (ALS TDI) and Augie’s Quest to Cure ALS are proud to honor the commitment of Liz Bodine to facilitate more effective ALS drug discovery at ALS TDI, the world’s most comprehensive drug discovery lab dedicated solely to ALS. - May 04, 2022 - ALS Therapy Development Institute

Dr. Ralph McNutt, Jr. Celebrated as a Top Executive of 2022 by Strathmore's Who's Who Worldwide Publication

Dr. Ralph McNutt, Jr. Celebrated as a Top Executive of 2022 by Strathmore's Who's Who Worldwide Publication

Dr. Ralph L. McNutt, Jr. of Ellicott City, Maryland has been selected as a Top Executive of 2022 by Strathmore’s Who’s Who Worldwide Edition for his outstanding contributions and achievements in the field of education. About Dr. Ralph L. McNutt Dr. Ralph L. McNutt is a physicist and a... - May 04, 2022 - Strathmore Worldwide

Cyclists Support ALS Research with 3-Day, 270-Mile Ride from Boston to Greenwich in Tri-State Trek

Cyclists Support ALS Research with 3-Day, 270-Mile Ride from Boston to Greenwich in Tri-State Trek

Hundreds of riders to join the ride to end ALS this June and raise funds for cutting-edge ALS research. ALS TDI has received a $100,000 match for all donations made to the Tri-State Trek through the month of May. - May 03, 2022 - ALS Therapy Development Institute

Creative Diagnostics Introduces New Nipah Virus Antigens and Antibodies

Creative Diagnostics recently launches a series of NiV recombinant antigen and antibody pairs. - April 30, 2022 - Creative Diagnostics

Multimillionaire CEO Eun Um Celebrates Her 17th Anniversary at AMSTAT Consulting

Multimillionaire CEO Eun Um Celebrates Her 17th Anniversary at AMSTAT Consulting

Dr. Eun Um, a self-made multimillionaire and president and CEO of AMSTAT Consulting, explained how she managed the company for 17 years. She said, "Execution is the secret." After graduating from Stanford and Columbia Universities, Dr. Um designed and managed clinical trials at Harvard... - April 21, 2022 - AMSTAT Consulting

Biolexis Therapeutics Announces Poster Presentation at AACR 2022 Annual Meeting

Biolexis Therapeutics Inc., a leader in bio-tech research and creator of the FIELDS™ process, today announced that data highlighting an orally available, CDK9 selective small molecule inhibitor showing promise in n-Myc-driven neuroendocrine prostate cancers (NEPC) was presented in a poster at... - April 11, 2022 - Biolexis Therapeutics Inc.

Speakers at the Community of Human and Organizational Learning Conference Includes a Global C-Suite Lineup

Speakers at the Community of Human and Organizational Learning Conference Includes a Global C-Suite Lineup

The 2022 Learning Conference will ask the attendees the right questions, provide the latest research and teach practical tools to strengthen systems, accelerating organizational learning and resilience. - April 01, 2022 - Community of Human and Organizational Learning

Med Bed Technology Products Now Beginning to be Released to Public

Med Bed Technology Products Now Beginning to be Released to Public

What is a "med bed" and when are med beds coming? Although the release of med beds mentioned in various underground programs have not been released yet there are many med bed light frequency technologies and technology products now providing various health benefits to users. Hospital Direct Medical looks at Tesla Plasma Chambers, Terahertz Wands, Tesla Ozone Ray's, Anti Aging Bed Covers and other products are now available. - March 28, 2022 - Hospital Direct Medical Equipment Inc.

Oaklea Press to Give Away 1000s of Copies of a Book That Purports to Solve "The Hard Problem of Consciousness"

Oaklea Press to Give Away 1000s of Copies of a Book That Purports to Solve "The Hard Problem of Consciousness"

The publisher of The Oaklea Press has arranged for the Kindle edition of its title, “Consciousness, The Hard Problem Solved” to be free to download on March 23, 2022. - March 23, 2022 - The Oaklea Press

Synchronicity and Precognition: is It Real or an Illusion?

Synchronicity and Precognition: is It Real or an Illusion?

Is Synchronicity and Precognition Real or an illusion? In “Synchronicity and Precognition: Science or Fiction,” the author examines whether there is a scientific or realistic basis to these paranormal phenomena. Donald A. Eisner, Ph.D. J.D. evaluated the studies and came to several... - March 22, 2022 - Donald Eisner

Solaris Chem Products Are Now Available in Germany Through Hözel

Their distribution partner in Germany, Hözel, has included Solaris Chem's products to its range for the biotechnology sector. Hözel has been a well-established company since its foundation in 1993. Thanks to its long-standing market presence, it has a lot of experience and knowledge in... - March 19, 2022 - Solaris Chem Inc.

Press Releases 101 - 150 of 432